| The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials | Lancet Oncology, The | 2013 | 804 |
| Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial | Lancet, The | 2005 | 329 |
| Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging | Journal of Clinical Oncology | 2003 | 304 |
| Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis | NMR in Biomedicine | 2002 | 297 |
| Technology insight: water diffusion MRI--a potential new biomarker of response to cancer therapy | Nature Clinical Practice Oncology | 2008 | 279 |
| Phase I clinical trial of weekly combretastatin A4 phosphate: clinical and pharmacokinetic results | Journal of Clinical Oncology | 2003 | 275 |
| Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial | Journal of Clinical Oncology | 2006 | 244 |
| Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer | Clinical Cancer Research | 2008 | 222 |
| Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging: initial clinical results | Radiology | 2006 | 209 |
| Leukocyte DNA damage after multi-detector row CT: a quantitative biomarker of low-level radiation exposure | Radiology | 2007 | 191 |
| Hyperbaric oxygen and radiotherapy: a Medical Research Council trial in carcinoma of the cervix | British Journal of Radiology | 1978 | 188 |
| Role of tumour markers in monitoring epithelial ovarian cancer | British Journal of Cancer | 2000 | 168 |
| Chemical sensitizers for hypoxic cells: a decade of experience in clinical radiotherapy | Radiotherapy and Oncology | 1985 | 162 |
| BOLD MRI of human tumor oxygenation during carbogen breathing | Journal of Magnetic Resonance Imaging | 2001 | 160 |
| Use of CA-125 to define progression of ovarian cancer in patients with persistently elevated levels | Journal of Clinical Oncology | 2001 | 160 |
| Carcinoma of the cervix--anaemia, radiotherapy and hyperbaric oxygen | British Journal of Radiology | 1983 | 147 |
| Reproducibility and changes in the apparent diffusion coefficients of solid tumours treated with combretastatin A4 phosphate and bevacizumab in a two-centre phase I clinical trial | European Radiology | 2009 | 141 |
| Risk of second malignancy after non-Hodgkin's lymphoma: a British Cohort Study | Journal of Clinical Oncology | 2006 | 141 |
| Effects of 5,6-dimethylxanthenone-4-acetic acid on human tumor microcirculation assessed by dynamic contrast-enhanced magnetic resonance imaging | Journal of Clinical Oncology | 2002 | 139 |
| Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: an interim report. CHART Steering Committee | British Journal of Cancer | 1996 | 139 |
| Experience with CHART | International Journal of Radiation Oncology Biology Physics | 1991 | 136 |
| Hyperbaric oxygen: the Medical Research Council trials and their clinical significance | British Journal of Radiology | 1978 | 133 |
| The recording of morbidity related to radiotherapy | Radiotherapy and Oncology | 1989 | 127 |
| Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer | British Journal of Cancer | 2005 | 126 |
| Misonidazole-a drug for trial in radiotherapy and oncology | International Journal of Radiation Oncology Biology Physics | 1979 | 118 |
